Coming SoonTandem Mobi
+ Android
The world's smallest, durable automated insulin delivery system,1 will soon be available with compatible Android smartphones.
Predicts and Helps Prevent Highs & Lows
Tandem Mobi is powered by Control‑IQ+ technology — the tested and trusted system that delivers best-in-class outcomes. Now Android users can finetune their diabetes management by creating a customized experience with up to six profiles.
Hey, Android Users!
Soon you can get the tiny pump that’s big on control by signing up for early access.
Wearability Like Never Before
The pump is so small that it can be worn almost anywhere,* giving you more options for comfort and wearability than ever before.
Wear it on-body with an adhesive sleeve (sold separately), which is compatible with all infusion sets, including the AutoSoft XC with 5‑inch tubing.
Clip it easily to your clothes, dress, workout gear, or pajamas. Tandem Mobi can be worn almost anywhere.*
The impressively small Tandem Mobi is so discreet that you can simply slip it into the coin pocket of your jeans (yes, it’s that small).
Reconnect.
It’s a snap!
Itʼs easy to temporarily disconnect an infusion set from your Tandem Mobi for showering, hot tubs, or contact sports.
#1 Favorite Pump
You may be able to experience the life-changing benefits of Tandem automated insulin delivery for $0 out of pocket.
Seagrove PWD Survey: Nov. 2024.
Cost per day calculation reflects the average monthly out-of-pocket cost for pump and disposables necessary to utilize Tandem pump therapy over the life of the 48-month pump warranty. Assumes consumption of 10 infusion sets and cartridges per month.
$0 out of pocket claim based on direct orders from Tandem customers with commercial insurance from 1/1/2025-12/31/2025. Data on file. Actual cost may vary and is subject to individual insurance coverage.
Wake Up and Do What Moves You
Control-IQ+ technology includes a dedicated Sleep Activity that uses a narrower and lower range of treatment values to help guard against lows and highs while sleeping.
Android Device Compatibility
The Tandem Mobi mobile app can be downloaded from Google Play on compatible Android smartphones, including Google Pixel models 6 through 10 and Samsung Galaxy models S21 through S25.
Additional Features
Inductive Charging
Holds 200 units of Insulin
Water-Resistant (IP28)†
CGM Sensors‡
The Tandem Mobi system currently integrates with Dexcom G6 and standard Dexcom G7 (10-Day) sensors.
Infusion Sets
The system is compatible with all Tandem infusion sets, so you can choose the length, angle, and material that best fits your lifestyle.
Ready to order the Tandem Mobi system?
Note: Adhesive sleeve sold separately.
* Do not wear or place your pump more than 12 inches (30.5 cm) above your infusion site. Doing so may result in over delivery of insulin.
† Tested at 8feet for 2 hours (IP28 rating).
‡ CGM sold separately.
Reference
As of Nov., 2025. Data on file, Tandem Diabetes Care.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient use. The pump is indicated for use in individuals 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The Tandem Mobi system with Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater. Control-IQ+ technology is intended for single patient use. Control-IQ+ technology is indicated for use with NovoLog or Humalog U-100 insulin.
Warning: Control-IQ+ technology should not be used by anyone under the age of 2 years old. It should also not be used in patients who require less than 5 units of insulin per day or who weigh less than 20 pounds.
Control-IQ+ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ+ technology if using hydroxyurea. Users of the Tandem Mobi pump and Control-IQ+ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. If your CGM readings do not match your symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. The Tandem Mobi pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit tandemdiabetes.com/safetyinfo for additional important safety information.